| Date Filed | Type | Description |
| 02/02/2023 |
SC 13G/A
| Societe des Produits Nestle S.A. reports a 15.1% stake in Axcella Health Inc. |
| 10/19/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/17/2022 |
4
| Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 3,658,536 shares
@ $1.64, valued at
$6M
|
|
| 03/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
3
| NESTLE SA (10% Owner) has filed a Form 3 on Prometheus Biosciences, Inc. |
| 02/12/2021 |
SC 13G/A
| Societe des Produits Nestle S.A. reports a 11.5% stake in Axcella Health Inc. |
| 10/15/2020 |
4
| Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Bought 43,435,583 shares
@ $34.5, valued at
$1498.5M
Bought 10,681,704 shares
@ $34.5, valued at
$368.5M
|
|
| 10/13/2020 |
SC 13D/A
| Societe des Produits Nestle S.A. reports a 100% stake in Aimmune Therapeutics, Inc. |
| 10/13/2020 |
SC 13E3/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/05/2020 |
SC 13E3/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/05/2020 |
SC 13E3/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/29/2020 |
SC 13E3/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/21/2020 |
SC 13E3/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/14/2020 |
SC 13E3
| Form SC TO-T - Tender offer statement by Third Party: |
| 09/14/2020 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 09/09/2020 |
4
| Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Acquired 4,305,541 shares
@ $4.42, valued at
$19M
|
|
| 08/31/2020 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 08/31/2020 |
SC 13D/A
| Societe des Produits Nestle S.A. reports a 19.6% stake in Aimmune Therapeutics, Inc. |
| 05/21/2020 |
4
| Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 1,936,842 shares
@ $4.75, valued at
$9.2M
|
|
| 04/24/2020 |
4
| Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Bought 1,000,000 shares
@ $31.97, valued at
$32M
Bought 525,634 preferred shares
@ $319.675, valued at
$168M
Acquired 12,727,113 shares
@ $16.11, valued at
$205M
Acquired 525,634 preferred shares
@ $161.1, valued at
$84.7M
|
|
| 04/24/2020 |
3
| Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 3 on Aimmune Therapeutics, Inc. |
| 02/14/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |